Investors
Press Releases
Recent Press Releases
Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
January 19, 2021
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 12, 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
January 05, 2021
Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"
December 31, 2020
AMERI Holdings Announces 1-for-4 Reverse Stock Split
December 30, 2020
Jay Pharma Announces IRB Approval for Testing Proprietary CBD Formulation in Glioblastoma Multiforme (GBM)
June 02, 2020
Jay Pharma 2020 Shareholder Letter
February 24, 2020
George A. Kegler Jr. to Join Jay Pharma as Director and Audit Committee Chair
February 20, 2020
Sarah Dakar Joins Jay Pharma as Vice President, Product Development
February 18, 2020
Ameri Holdings to Merge with Jay Pharma Inc., Evidence-Based Cannabinoid Medicine & Wellness Company Focused on Cancer
January 13, 2020
January 19, 2021
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 12, 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
January 05, 2021
Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"
December 31, 2020
AMERI Holdings Announces 1-for-4 Reverse Stock Split
December 30, 2020
Jay Pharma Announces IRB Approval for Testing Proprietary CBD Formulation in Glioblastoma Multiforme (GBM)
June 02, 2020
Jay Pharma 2020 Shareholder Letter
February 24, 2020
George A. Kegler Jr. to Join Jay Pharma as Director and Audit Committee Chair
February 20, 2020
Sarah Dakar Joins Jay Pharma as Vice President, Product Development
February 18, 2020
Ameri Holdings to Merge with Jay Pharma Inc., Evidence-Based Cannabinoid Medicine & Wellness Company Focused on Cancer
January 13, 2020
